公司调查 - Kuehn Law PLLC正在调查Bakkt Holdings Inc (NASDAQ: BKKT)的某些高管和董事是否违反了对股东的受托责任 [1] 诉讼指控 - 根据联邦证券诉讼，Bakkt内部人士导致公司对以下事项进行虚假陈述或未披露：(1) 其加密服务收入的稳定性和/或多样性 (2) Bakkt的加密服务收入严重依赖于与Webull的单一合同 (3) Bakkt维持关键客户关系的能力 [2] - 由于上述原因，公司关于业务、运营和前景的正面陈述存在重大误导性和/或缺乏合理依据 [2] 股东参与 - 股东参与有助于维护金融市场的完整性和公平性 [4] - 股东可通过指定联系方式与Kuehn Law联系以维护自身权益 [3]

NEW YORK, May 28, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Viatris Inc. (NASDAQ: VTRS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Viatris caused the company to misrepresent or fail to disclose information concerning the failed inspection of Viatris' Indore, India facility, including, (1) when the inspection occurred, (2) how long the remediation efforts had ...

文章核心观点 Kuehn Law律所调查TransMedics Group公司高管和董事是否对股东违反信托责任 [1] 调查原因 - 联邦证券诉讼称公司内部人员致使公司存在不当行为，包括使用回扣、欺诈性过度计费和强制策略来创收，从事不安全业务并隐瞒安全问题、缺乏安全监督，使公司面临更高审查和监管风险，相关业务、运营和前景陈述存在重大虚假误导或缺乏合理依据 [2] 股东参与 - 若目前持有TMDX且于2023年2月28日前购买，可联系Justin Kuehn，律所承担所有案件费用且不向投资者客户收费，股东应尽快联系以维护权益 [3] - 股东参与有助于金融市场的诚信和公平 [4]

公司诉讼案件 - Organon公司因涉嫌违反1934年证券交易法被起诉 案件编号为Hauser v Organon & Co No 25-cv-05322 [1] - 诉讼指控公司高管在股息分配优先级和债务削减策略方面存在虚假或误导性陈述 导致季度股息骤降超70% [4] - 2025年5月1日公司宣布将季度股息从每股0 28美元下调至0 02美元 股价当日暴跌27% [5] 公司业务背景 - Organon主营业务为通过处方疗法和医疗设备提供健康解决方案 [3] - 公司收购Dermavant Sciences Ltd后转向优先实施债务削减策略 [4] 法律程序信息 - 潜在原告需在2025年7月22日前提交主导原告动议 [2] - 主导原告将代表全体集体诉讼成员并有权选择代理律所 [6] 代理律所资质 - Robbins Geller律所在证券欺诈诉讼领域具有领先地位 2024年为投资者追回25亿美元赔偿 [7] - 该律所曾创下72亿美元的历史最高证券集体诉讼赔偿纪录 [7]

NEW YORK, May 21, 2025 /PRNewswire/ -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating potential claims against: Paramount Group Inc. (NYSE: PGRE) Shareholders should email [email protected]; please contact only if shares acquired before 2022 The investigation concerns a Wall Street Journal article outing Chief Executive Albert Behler for tapping company coffers to the tune of $4,000,000.00 to fund his personal expenses and business interests and his wife's busin ...

公司诉讼案件 - 西氏医药服务公司因涉嫌违反1934年证券交易法被提起集体诉讼 案件编号为No 25-cv-02285 [1] - 诉讼指控公司在2023年2月16日至2025年2月12日期间做出虚假和/或误导性陈述 [1][3] - 诉讼涉及公司高管及前高管 原告为新英格兰卡车司机养老金基金 [1] 公司业务情况 - 西氏医药主要从事注射药物和医疗产品的密封包装和给药系统设计与制造 [2] - 公司高利润的高价值产品组合持续经历显著去库存 与公司声称的"临时性COVID相关去库存"不符 [3] - SmartDose设备因运营效率低下严重稀释公司利润率 该产品本被定位为高利润增长产品 [3] 财务与运营问题 - 公司2025年收入指引为28 8-29 1亿美元 大幅低于预期 [4] - 利润率压力导致公司退出长期客户的连续血糖监测(CGM)合同 [3] - SmartDose可穿戴注射器因降价将在2025年继续稀释利润率 [4] 市场反应 - 2025年2月13日公司发布上述消息后 股价暴跌超过38% [4] - 公司解释业绩不佳部分原因是合同制造业务面临挑战 包括失去两个主要CGM客户 [4]

SAN DIEGO, May 18, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Civitas Resources, Inc. (NYSE: CIVI) securities between February 27, 2024 and February 24, 2025, all dates inclusive (the “Class Period”), have until July 1, 2025 to seek appointment as lead plaintiff of the Civitas Resources class action lawsuit. Captioned Lin v. Civitas Resources, Inc., No. 25-cv-03791 (D.N.J.), the Civitas Resources class action lawsuit charges Civitas Resources as well ...

公司调查 - 顶级股东权利律师事务所Julie & Holleman LLP正在调查Ibotta Inc及其高管可能存在的索赔案件 因公司股东近期遭受损失 [1] - 调查涉及Ibotta及其高管可能误导投资者关于其大客户The Kroger Co相关风险的信息 且公司IPO价格为每股88美元后股价大幅下跌 [2] - 律师事务所正在调查针对Ibotta高管及董事会的法律索赔 该律所此前在类似案件中已帮助客户获得数亿美元赔偿 [3] 律所背景 - Julie & Holleman为专注于股东诉讼的精品律所 业务范围包括衍生诉讼 并购案件 证券欺诈集体诉讼及公司调查 [4] - 律所律师在全美各州及联邦法院参与诉讼 累计为公司及股东挽回数亿美元损失 [4]

NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Doximity, Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Doximity caused the company to misrepresent or fail to disclose material information concerning the Company’s business and operations. Specifically, the Complaint alleges Defendants repeatedly touted the Company’s business pro ...

NEW YORK, May 14, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of SoundHound AI, Inc. (NASDAQ: SOUN) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at SoundHound caused the company to misrepresent or fail to disclose that (i) the material weaknesses in SoundHound's internal controls over financial reporting impaired the Company's ability to effectively account for corpora ...